These changes explain the range of gastrointestinal symptoms patients experience, from diarrhea to constipation
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept
Although these data appear to conflict with our observation that tirzepatide stimulates alpha cell activity, it is important to note that the metabolic profile of the subjects in the tirzepatide arm improved dramatically during the 28-week period, complicating interpretations
[2] [6] Patients with diabetes and retinopathy should discuss ophthalmologic monitoring
By fueling your body right, staying hydrated, and working closely with a knowledgeable provider, you can manage the tiredness and keep moving toward your weight loss goals
5-Amino-1MQ is a small molecule that works as an NNMT inhibitor